Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2023 Publisher: Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip HA4 6QD, United Kingdom
Candesartan cilexetil 16 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Yellow, biconvex, uncoated, round shaped [diameter 7.3 mm] tablets debossed with “CN” and “16” separated by scoreline on one side and plain on other side. The tablet can be divided into equal doses. |
Each tablet contains 16 mg candesartan cilexetil.
Excipient with known effect: Lactose monohydrate.
Each tablet contains 125.60 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Candesartan |
Candesartan is an AIIRA, selective for AT1 receptors, with tight binding to and slow dissociation from the receptor. It has no agonist activity. The antagonism of the angiotensin II (AT1) receptors results in dose related increases in plasma renin levels, angiotensin I and angiotensin II levels, and a decrease in plasma aldosterone concentration. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Candesartan Cilexetil tablets are available in PVC/PVdC – Aluminium foil blister pack and HDPE container pack with polypropylene closure.
Pack sizes:
Blister pack: 7, 28, 30, 56, 90, 98 & 500 tablets.
HDPE pack: 30, 90 & 500 tablets.
Not all pack sizes may be marketed.
Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip HA4 6QD, United Kingdom
PL 16363/0381
12/07/2013 / 11/10/2023
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
